pBudCE4.1 Mammalian Expression Vector
Product Image
Invitrogen™

pBudCE4.1 Mammalian Expression Vector

El vector pBudCE4.1 está diseñado para la expresión independiente de dos genes a partir de un plásmido único en célulasMás información
Have Questions?
Número de catálogoCantidad
V5322020μg
Número de catálogo V53220
Precio (USD)
1.548,72
20 µg
Añadir al carro de la compra
Cantidad:
20μg
Precio (USD)
1.548,72
20 µg
Añadir al carro de la compra
El vector pBudCE4.1 está diseñado para la expresión independiente de dos genes a partir de un plásmido único en células de mamíferos. El uso de pBudCE4.1 para generar líneas celulares estables de expresión en mamíferos garantiza que haya un número de copia equivalente de cada gen en la célula. Esto puede eliminar la expresión variable debido a las diferencias en el número de copia génica. pBudCE4.1 proporciona casetes de expresión con las siguientes características:

El promotor del CMV para la transcripción de alto nivel de genes con la etiqueta de epítopo c-myc opcional para una detección rápida y secuencia 6xHis para la purificación simple

• Promotor EF-1α humano para la expresión de alto nivel de genes con etiqueta de epítopo V5 opcional para detección rápida y secuencia 6xHis para la purificación simple
• Gen Sh ble (ZeoR) para una selección eficaz en células de mamíferos y E. coli con el agente de selección Zeocin™
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Sistema constitutivo o inducibleConstitutivo
Tipo de entregaTransfección
Para utilizar con (aplicación)Expresión multigénica
Tipo de productoVector de expresión de mamíferos
Cantidad20μg
Agente de selección (eucariótico)Zeocin™
VectorpBud
Método de clonaciónEnzimas de restricción/MCS
PromotorEF-1α, CMV
Etiqueta de proteínaEtiqueta His (6x), Etiqueta de epítopo V5, Etiqueta de epítopo c-Myc
Unit Size20 µg
Contenido y almacenamiento
20 μg cada uno de los vectores de control positivo pBudCE4.1 y pBudCE4.1/lacZ/CAT que se suministran superenrollados y liofilizados. Conservar a -20°C. Se garantiza la estabilidad de los vectores durante 6 meses si se almacenan correctamente.

Preguntas frecuentes

I would like to coexpress 2 genes in the same cell line followed by stable selection. Do you have any suggestions?

You can accomplish this by designing a bicistronic transcript, in which the two genes are separated by an internal ribosome entry site (IRES) sequence and are expressed as a single transcriptional cassette under the control of a common upstream promoter. Alternatively, you can use a vector containing two separate promoters to drive expression of the two genes, thus maintaining the gene copy number within the cells. We offer the pBud/CE4.1 vector, Cat. No. V53220, designed for the independent expression of two genes from a single plasmid. It contains the CMV and EF1alpha promoters to provide almost equivalent expression of the two genes being expressed. It carries the Zeocin antibiotic-resistance marker for stable selection.

I performed stable selection but my antibiotic-resistant clones do not express my gene of interest. What could have gone wrong?

Here are possible causes and solutions:

Detection method may not be appropriate or sensitive enough:
- We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot.
- Insufficient number of clones screened: Screen at least 20 clones.
- Inappropriate antibiotic concentration used for stable selection: Make sure the antibiotic kill curve was performed correctly. Since the potency of a given antibiotic depends upon cell type, serum, medium, and culture technique, the dose must be determined each time a stable selection is performed. Even the stable cell lines we offer may be more or less sensitive to the dose we recommend if the medium or serum is significantly different.
- Expression of gene product (even low level) may not be compatible with growth of the cell line: Use an inducible expression system.
- Negative clones may result from preferential linearization at a vector site critical for expression of the gene of interest: Linearize the vector at a site that is not critical for expression, such as within the bacterial resistance marker.

I used a mammalian expression vector but do not get any expression of my protein. Can you help me troubleshoot?

Here are possible causes and solutions:

- Try the control expression that is included in the kit
Possible detection problem:

- Detection of expressed protein may not be possible in a transient transfection, since the transfection efficiency may be too low for detection by methods that assess the entire transfected population. We recommend optimizing the transfection efficiency, doing stable selection, or using methods that permit examination of individual cells. You can also increase the level of expression by changing the promoter or cell type.
- Expression within the cell may be too low for the chosen detection method. We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot. Protein might be degraded or truncated: Check on a Northern. Possible time-course issue: Since the expression of a protein over time will depend upon the nature of the protein, we always recommend doing a time course for expression. A pilot time-course assay will help to determine the optimal window for expression. Possible cloning issues: Verify clones by restriction digestion and/or sequencing.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I am using a mammalian expression vector that has the neomycin resistance gene. Can I use neomycin for stable selection in mammalian cells?

No; neomycin is toxic to mammalian cells. We recommend using Geneticin (a.k.a. G418 Sulfate), as it is a less toxic and very effective alternative for selection in mammalian cells.

Is it okay if my construct has an ATG that is upstream of the ATG in my gene of interest? Will it interfere with translation of my gene?

Translation initiation will occur at the first ATG encountered by the ribosome, although in the absence of a Kozak sequence, initiation will be relatively weak. Any insert downstream would express a fusion protein if it is in frame with this initial ATG, but levels of expressed protein are predicted to be low if there is a non-Kozak consensus sequence. If the vector contains a non-Kozak consensus ATG, we recommend that you clone your gene upstream of that ATG and include a Kozak sequence for optimal expression.

Citations & References (6)

Citations & References
Abstract
Human Pumilio-2 is expressed in embryonic stem cells and germ cells and interacts with DAZ (Deleted in AZoospermia) and DAZ-like proteins.
Authors:Moore FL, Jaruzelska J, Fox MS, Urano J, Firpo MT, Turek PJ, Dorfman DM, Pera RA,
Journal:Proc Natl Acad Sci U S A
PubMed ID:12511597
'Early in development, a part of the embryo is set aside to become the germ cell lineage that will ultimately differentiate to form sperm and eggs and transmit genetic information to the next generation. Men with deletions encompassing the Y-chromosome DAZ genes have few or no germ cells but are ... More
Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation.
Authors:Goodchild RE, Dauer WT,
Journal:Proc Natl Acad Sci U S A
PubMed ID:14711988
'Primary dystonia is a disease characterized by involuntary twisting movements caused by CNS dysfunction without underlying histopathology. DYT1 dystonia is a form of primary dystonia caused by an in-frame GAG deletion (DeltaE302/3) in the TOR1A gene that encodes the endoplasmic reticulum luminal protein torsinA. We show that torsinA is also ... More
Functional analysis of tryptophans alpha 62 and beta 120 on HLA-DM.
Authors: Faubert Amélie; Samaan Angela; Thibodeau Jacques;
Journal:J Biol Chem
PubMed ID:11713260
'In the endocytic pathway of antigen-presenting cells, HLA-DM catalyzes the exchange between class II-associated invariant chain peptide (CLIP) and antigenic peptides onto major histocompatibility complex class II molecules. At low pH of lysosomal compartments, both HLA-DM and HLA-DR undergo conformational changes, and it was recently postulated that two partially exposed ... More
Thyrostimulin, a heterodimer of two new human glycoprotein hormone subunits, activates the thyroid-stimulating hormone receptor.
Authors: Nakabayashi Koji; Matsumi Hirotaka; Bhalla Alka; Bae Jeehyeon; Mosselman Sietse; Hsu Sheau Yu; Hsueh Aaron J W;
Journal:J Clin Invest
PubMed ID:12045252
Human thyrotropin (TSH), luteotropin (LH), follitropin (FSH), and chorionic gonadotropin are members of the heterodimeric glycoprotein hormone family. The common alpha subunit forms noncovalent heterodimers with different beta subunits. Two novel human glycoprotein hormonelike genes, alpha2 (A2) and beta5 (B5), recently have been identified. Using a yeast two-hybrid assay, the ... More
Modulation of polyglutamine-induced cell death by genes identified by expression profiling.
Authors: Kita Hiroko; Carmichael Jenny; Swartz Jina; Muro Shizuko; Wyttenbach Andreas; Matsubara Kenichi; Rubinsztein David C; Kato Kikuya;
Journal:Hum Mol Genet
PubMed ID:12217956
The majority of triplet-repeat diseases are caused by mutated genes with an extended polyglutamine tract, exemplified by Huntington's disease (HD). In order to model HD pathogenesis in a controlled system, we developed stable PC12 cell lines that express exon 1 fragments of the huntingtin gene with 23 or 74 polyglutamines ... More